RGEN - MAIA stock climbs on positive Phase 2 data for lung cancer therapy October, 24 2023 09:46 AM Repligen Corporation 2023-10-24 09:46:03 ET More on MAIA Biotechnology Seeking Alpha’s Quant Rating on MAIA Biotechnology Historical earnings data for MAIA Biotechnology Financial information for MAIA Biotechnology For further details see: MAIA stock climbs on positive Phase 2 data for lung cancer therapy